Fla. Stat. 381.0038
Education; sterile needle and syringe exchange programs


(1)

The acquired immune deficiency syndrome education program shall:Be designed to reach all segments of Florida’s population;Contain special components designed to reach non-English-speaking and other minority groups within the state;Impart knowledge to the public about methods of transmission of acquired immune deficiency syndrome and methods of prevention;Educate the public about transmission risks in social, employment, and educational situations;Educate health care workers and health facility employees about methods of transmission and prevention in their unique workplace environments;Contain special components designed to reach persons who may frequently engage in behaviors placing them at a high risk for acquiring acquired immune deficiency syndrome;Provide information and consultation to state agencies to educate all state employees;Provide information and consultation to state and local agencies to educate law enforcement and correctional personnel and inmates;Provide information and consultation to local governments to educate local government employees;Make information available to private employers and encourage them to distribute this information to their employees;Contain special components which emphasize appropriate behavior and attitude change; andContain components that include information about domestic violence and the risk factors associated with domestic violence and AIDS.

(a)

Be designed to reach all segments of Florida’s population;

(b)

Contain special components designed to reach non-English-speaking and other minority groups within the state;

(c)

Impart knowledge to the public about methods of transmission of acquired immune deficiency syndrome and methods of prevention;

(d)

Educate the public about transmission risks in social, employment, and educational situations;

(e)

Educate health care workers and health facility employees about methods of transmission and prevention in their unique workplace environments;

(f)

Contain special components designed to reach persons who may frequently engage in behaviors placing them at a high risk for acquiring acquired immune deficiency syndrome;

(g)

Provide information and consultation to state agencies to educate all state employees;

(h)

Provide information and consultation to state and local agencies to educate law enforcement and correctional personnel and inmates;

(i)

Provide information and consultation to local governments to educate local government employees;

(j)

Make information available to private employers and encourage them to distribute this information to their employees;

(k)

Contain special components which emphasize appropriate behavior and attitude change; and

(l)

Contain components that include information about domestic violence and the risk factors associated with domestic violence and AIDS.

(2)

The education program designed by the Department of Health shall use all forms of the media and shall place emphasis on the design of educational materials that can be used by businesses, schools, and health care providers in the regular course of their business.

(3)

The department may contract with other persons in the design, development, and distribution of the components of the education program.

(4)

A county commission may authorize a sterile needle and syringe exchange program to operate within its county boundaries. The program may operate at one or more fixed locations or through mobile health units. The program shall offer the free exchange of clean, unused needles and hypodermic syringes for used needles and hypodermic syringes as a means to prevent the transmission of HIV, AIDS, viral hepatitis, or other blood-borne diseases among intravenous drug users and their sexual partners and offspring. Prevention of disease transmission must be the goal of the program. For the purposes of this subsection, the term “exchange program” means a sterile needle and syringe exchange program established by a county commission under this subsection. A sterile needle and syringe exchange program may not operate unless it is authorized and approved by a county commission in accordance with this subsection.Before an exchange program may be established, a county commission must:
Authorize the program under the provisions of a county ordinance;
Enter into a letter of agreement with the department in which the county commission agrees that any exchange program authorized by the county commission will operate in accordance with this subsection;
Enlist the local county health department to provide ongoing advice, consultation, and recommendations for the operation of the program;
Contract with one of the following entities to operate the program:
A hospital licensed under chapter 395.
A health care clinic licensed under part X of chapter 400.
A medical school in this state accredited by the Liaison Committee on Medical Education or the Commission on Osteopathic College Accreditation.
A licensed addictions receiving facility as defined in s. 397.311(27)(a)1.
A s. 501(c)(3) HIV/AIDS service organization.
An exchange program must:
Develop an oversight and accountability system to ensure the program’s compliance with statutory and contractual requirements. The system must include measurable objectives for meeting the goal of the program and must track the progress in achieving those objectives. The system must require the program operator to routinely report its progress in achieving the objectives and the goal of the program. The system must also incorporate mechanisms to track the program operator’s compliance or noncompliance with contractual obligations and to apply consequences for noncompliance. The program must receive the county commission’s approval of the oversight and accountability system before commencing operations.
Provide for maximum security of sites where needles and syringes are exchanged and of any equipment used under the program, including, at a minimum, an accounting of the number of needles and syringes in use, the number of needles and syringes in storage, safe disposal of returned needles, and any other measure that may be required to control the use and dispersal of sterile needles and syringes.
Operate a one-to-one exchange, whereby a participant shall receive one sterile needle and syringe unit in exchange for each used one.
Make available educational materials regarding the transmission of HIV, viral hepatitis, and other blood-borne diseases. The program operator must offer such materials to program participants whenever needles or syringes are exchanged.
Provide onsite counseling or referrals for drug abuse prevention, education, and treatment, and provide onsite HIV and viral hepatitis screening or referrals for such screening. If such services are offered solely by referral, they must be made available to participants within 72 hours. The county commission in a rural county may, under its contract with the program operator, adjust the 72-hour requirement if the commission finds that the availability of providers warrants an extended timeframe.
Provide kits containing an emergency opioid antagonist, as defined in s. 381.887, or provide referrals to a program that can provide such kits.
Collect data for annual reporting purposes. The data must include the number of participants served; the number of used needles and syringes received and the number of clean, unused needles and syringes distributed through exchange with participants; the demographic profiles of the participants served; the number of participants entering drug counseling or treatment; the number of participants receiving testing for HIV, AIDS, viral hepatitis, or other blood-borne diseases; and other data that may be required under department rule. However, a participant’s personal identifying information may not be collected for any purpose. Each exchange program shall submit a report to its county commission and to the department by August 1 annually. The department shall submit a compilation report encompassing data from all exchange programs annually by October 1 to the Governor, the President of the Senate, and the Speaker of the House of Representatives. The department may adopt rules to implement this subparagraph.
The possession, distribution, or exchange of needles or syringes as part of an exchange program established under this subsection is not a violation of any part of chapter 893 or any other law.An exchange program staff member, volunteer, or participant is not immune from criminal prosecution for:
The possession of needles or syringes that are not a part of the exchange program; or
The redistribution of needles or syringes in any form, if acting outside the exchange program.
A law enforcement officer acting in good faith who arrests or charges a person who is thereafter determined to be immune from prosecution under this section shall be immune from civil liability that might otherwise be incurred or imposed by reason of the officer’s actions.State, county, or municipal funds may not be used to operate an exchange program. Exchange programs shall be funded through grants and donations from private resources and funds.

(a)

Before an exchange program may be established, a county commission must:Authorize the program under the provisions of a county ordinance;Enter into a letter of agreement with the department in which the county commission agrees that any exchange program authorized by the county commission will operate in accordance with this subsection;Enlist the local county health department to provide ongoing advice, consultation, and recommendations for the operation of the program;Contract with one of the following entities to operate the program:
A hospital licensed under chapter 395.
A health care clinic licensed under part X of chapter 400.
A medical school in this state accredited by the Liaison Committee on Medical Education or the Commission on Osteopathic College Accreditation.
A licensed addictions receiving facility as defined in s. 397.311(27)(a)1.
A s. 501(c)(3) HIV/AIDS service organization.
1. Authorize the program under the provisions of a county ordinance;
2. Enter into a letter of agreement with the department in which the county commission agrees that any exchange program authorized by the county commission will operate in accordance with this subsection;
3. Enlist the local county health department to provide ongoing advice, consultation, and recommendations for the operation of the program;
4. Contract with one of the following entities to operate the program:a. A hospital licensed under chapter 395.b. A health care clinic licensed under part X of chapter 400.c. A medical school in this state accredited by the Liaison Committee on Medical Education or the Commission on Osteopathic College Accreditation.d. A licensed addictions receiving facility as defined in s. 397.311(27)(a)1.e. A s. 501(c)(3) HIV/AIDS service organization.
a. A hospital licensed under chapter 395.
b. A health care clinic licensed under part X of chapter 400.
c. A medical school in this state accredited by the Liaison Committee on Medical Education or the Commission on Osteopathic College Accreditation.
d. A licensed addictions receiving facility as defined in s. 397.311(27)(a)1.
e. A s. 501(c)(3) HIV/AIDS service organization.

(b)

An exchange program must:Develop an oversight and accountability system to ensure the program’s compliance with statutory and contractual requirements. The system must include measurable objectives for meeting the goal of the program and must track the progress in achieving those objectives. The system must require the program operator to routinely report its progress in achieving the objectives and the goal of the program. The system must also incorporate mechanisms to track the program operator’s compliance or noncompliance with contractual obligations and to apply consequences for noncompliance. The program must receive the county commission’s approval of the oversight and accountability system before commencing operations.Provide for maximum security of sites where needles and syringes are exchanged and of any equipment used under the program, including, at a minimum, an accounting of the number of needles and syringes in use, the number of needles and syringes in storage, safe disposal of returned needles, and any other measure that may be required to control the use and dispersal of sterile needles and syringes.Operate a one-to-one exchange, whereby a participant shall receive one sterile needle and syringe unit in exchange for each used one.Make available educational materials regarding the transmission of HIV, viral hepatitis, and other blood-borne diseases. The program operator must offer such materials to program participants whenever needles or syringes are exchanged.Provide onsite counseling or referrals for drug abuse prevention, education, and treatment, and provide onsite HIV and viral hepatitis screening or referrals for such screening. If such services are offered solely by referral, they must be made available to participants within 72 hours. The county commission in a rural county may, under its contract with the program operator, adjust the 72-hour requirement if the commission finds that the availability of providers warrants an extended timeframe.Provide kits containing an emergency opioid antagonist, as defined in s. 381.887, or provide referrals to a program that can provide such kits.Collect data for annual reporting purposes. The data must include the number of participants served; the number of used needles and syringes received and the number of clean, unused needles and syringes distributed through exchange with participants; the demographic profiles of the participants served; the number of participants entering drug counseling or treatment; the number of participants receiving testing for HIV, AIDS, viral hepatitis, or other blood-borne diseases; and other data that may be required under department rule. However, a participant’s personal identifying information may not be collected for any purpose. Each exchange program shall submit a report to its county commission and to the department by August 1 annually. The department shall submit a compilation report encompassing data from all exchange programs annually by October 1 to the Governor, the President of the Senate, and the Speaker of the House of Representatives. The department may adopt rules to implement this subparagraph.
1. Develop an oversight and accountability system to ensure the program’s compliance with statutory and contractual requirements. The system must include measurable objectives for meeting the goal of the program and must track the progress in achieving those objectives. The system must require the program operator to routinely report its progress in achieving the objectives and the goal of the program. The system must also incorporate mechanisms to track the program operator’s compliance or noncompliance with contractual obligations and to apply consequences for noncompliance. The program must receive the county commission’s approval of the oversight and accountability system before commencing operations.
2. Provide for maximum security of sites where needles and syringes are exchanged and of any equipment used under the program, including, at a minimum, an accounting of the number of needles and syringes in use, the number of needles and syringes in storage, safe disposal of returned needles, and any other measure that may be required to control the use and dispersal of sterile needles and syringes.
3. Operate a one-to-one exchange, whereby a participant shall receive one sterile needle and syringe unit in exchange for each used one.
4. Make available educational materials regarding the transmission of HIV, viral hepatitis, and other blood-borne diseases. The program operator must offer such materials to program participants whenever needles or syringes are exchanged.
5. Provide onsite counseling or referrals for drug abuse prevention, education, and treatment, and provide onsite HIV and viral hepatitis screening or referrals for such screening. If such services are offered solely by referral, they must be made available to participants within 72 hours. The county commission in a rural county may, under its contract with the program operator, adjust the 72-hour requirement if the commission finds that the availability of providers warrants an extended timeframe.
6. Provide kits containing an emergency opioid antagonist, as defined in s. 381.887, or provide referrals to a program that can provide such kits.
7. Collect data for annual reporting purposes. The data must include the number of participants served; the number of used needles and syringes received and the number of clean, unused needles and syringes distributed through exchange with participants; the demographic profiles of the participants served; the number of participants entering drug counseling or treatment; the number of participants receiving testing for HIV, AIDS, viral hepatitis, or other blood-borne diseases; and other data that may be required under department rule. However, a participant’s personal identifying information may not be collected for any purpose. Each exchange program shall submit a report to its county commission and to the department by August 1 annually. The department shall submit a compilation report encompassing data from all exchange programs annually by October 1 to the Governor, the President of the Senate, and the Speaker of the House of Representatives. The department may adopt rules to implement this subparagraph.

(c)

The possession, distribution, or exchange of needles or syringes as part of an exchange program established under this subsection is not a violation of any part of chapter 893 or any other law.

(d)

An exchange program staff member, volunteer, or participant is not immune from criminal prosecution for:The possession of needles or syringes that are not a part of the exchange program; orThe redistribution of needles or syringes in any form, if acting outside the exchange program.
1. The possession of needles or syringes that are not a part of the exchange program; or
2. The redistribution of needles or syringes in any form, if acting outside the exchange program.

(e)

A law enforcement officer acting in good faith who arrests or charges a person who is thereafter determined to be immune from prosecution under this section shall be immune from civil liability that might otherwise be incurred or imposed by reason of the officer’s actions.

(f)

State, county, or municipal funds may not be used to operate an exchange program. Exchange programs shall be funded through grants and donations from private resources and funds.

Source: Section 381.0038 — Education; sterile needle and syringe exchange programs, https://www.­flsenate.­gov/Laws/Statutes/2024/0381.­0038 (accessed Aug. 7, 2025).

381.001
Public health system
381.002
Grant of title to prescriptive medical personal property to client
381.003
Communicable disease and AIDS prevention and control
381.004
HIV testing
381.005
Primary and preventive health services
381.006
Environmental health
381.008
Definitions of terms used in ss
381.009
Toilets required by department regulations
381.0011
Duties and powers of the Department of Health
381.0012
Enforcement authority
381.0016
County and municipal regulations and ordinances
381.0018
Application for and acceptance of gifts or grants
381.0019
Disposition of equipment and material
381.0021
Client welfare accounts
381.0022
Sharing confidential or exempt information
381.026
Florida Patient’s Bill of Rights and Responsibilities
381.028
Adverse medical incidents
381.0031
Epidemiological research
381.0034
Requirement for instruction on HIV and AIDS
381.0035
Educational course on HIV and AIDS
381.0038
Education
381.0039
Oversight of AIDS education programs
381.0041
Donation and transfer of human tissue
381.0042
Patient care for persons with HIV infection
381.0043
Blood Donor Protection Act
381.0045
Targeted outreach for pregnant women
381.0046
Statewide HIV and AIDS prevention campaign
381.0051
Family planning
381.0052
Dental health
381.0053
Comprehensive nutrition program
381.0055
Confidentiality and quality assurance activities
381.0056
School health services program
381.0057
Funding for school health services
381.0059
Background screening requirements for school health services personnel
381.0061
Administrative fines
381.0062
Supervision
381.0063
Drinking water funds
381.0064
Continuing education program for installation and use of onsite sewage treatment and disposal systems
381.0065
Onsite sewage treatment and disposal systems
381.0066
Onsite sewage treatment and disposal systems
381.0067
Corrective orders
381.0072
Food service protection
381.74
Establishment and maintenance of a central registry
381.75
Duties and responsibilities of the department
381.0075
Regulation of body-piercing salons
381.76
Eligibility for the brain and spinal cord injury program
381.78
Advisory council on brain and spinal cord injuries
381.79
Brain and Spinal Cord Injury Program Trust Fund
381.0081
Permit required to operate a migrant labor camp or residential migrant housing
381.82
Ed and Ethel Moore Alzheimer’s Disease Research Program
381.0082
Application for permit to operate migrant labor camp or residential migrant housing
381.0083
Permit for migrant labor camp or residential migrant housing
381.84
Comprehensive Statewide Tobacco Education and Use Prevention Program
381.0084
Application fees for migrant labor camps and residential migrant housing
381.0085
Revocation of permit to operate migrant labor camp or residential migrant housing
381.86
Institutional Review Board
381.0086
Rules
381.0087
Enforcement
381.88
Emergency allergy treatment
381.0088
Right of entry
381.89
Regulation of tanning facilities
381.91
Jessie Trice Cancer Prevention Program
381.93
Breast and cervical cancer early detection program
381.95
Medical facility information maintained for terrorism response purposes
381.96
Pregnancy support and wellness services
381.98
The Florida Public Health Institute, Inc.
381.0098
Biomedical waste
381.99
Rare Disease Advisory Council
381.0101
Environmental health professionals
381.0201
Technical and support services
381.0202
Laboratory services
381.0203
Pharmacy services
381.0204
Vital statistics
381.0205
Emergency medical services
381.0261
Summary of patient’s bill of rights
381.0303
Special needs shelters
381.00315
Public health advisories
381.00316
Discrimination by governmental and business entities based on health care choices
381.00318
Complaints and investigations regarding mandate prohibitions
381.00319
Prohibition on mask mandates and vaccination and testing mandates for educational institutions
381.00321
The right of medical conscience of health care providers and health care payors
381.00322
International health organization policies
381.402
Florida Reimbursement Assistance for Medical Education Program
381.0402
Area health education center network
381.0405
Office of Rural Health
381.0406
Rural health networks
381.00591
Department of Health
381.00593
Public school volunteer health care practitioner program
381.0601
Self-derived and directed-donor blood programs
381.00651
Periodic evaluation and assessment of onsite sewage treatment and disposal systems
381.00655
Connection of existing onsite sewage treatment and disposal systems to central sewerage system
381.735
Office of Minority Health and Health Equity
381.739
Short title
381.745
Definitions
381.755
Benefits not assignable
381.765
Retention of title to and disposal of equipment
381.00771
Definitions of terms used in ss
381.00773
Application of ss
381.775
Applicant and recipient records
381.00775
Tattoo artists
381.00777
Tattoo establishments
381.00779
Practice requirements
381.00781
Fees
381.00783
Grounds for discipline
381.00785
Criminal penalties
381.785
Recovery of third-party payments for funded services
381.00787
Tattooing prohibited
381.00789
Rulemaking
381.00791
Local laws and ordinances
381.814
Sickle Cell Disease Research and Treatment Grant Program
381.815
Sickle-cell program
381.825
Education and public awareness relating to Alzheimer’s disease and related forms of dementia
381.853
Florida Center for Brain Tumor Research
381.875
Enhanced potential pandemic pathogen research prohibited
381.885
Epinephrine auto-injectors
381.887
Emergency treatment for suspected opioid overdose
381.00893
Complaints by aggrieved parties
381.895
Standards for compressed air used for recreational diving
381.00895
Prohibited acts
381.00896
Nondiscrimination
381.00897
Access to migrant labor camps and residential migrant housing
381.911
Prostate Cancer Awareness Program
381.915
Casey DeSantis Cancer Research Program
381.922
William G. “Bill” Bankhead, Jr., and David Coley Cancer Research Program
381.925
Cancer Center of Excellence Award
381.931
Annual report on Medicaid expenditures
381.932
Breast cancer early detection and treatment referral program
381.933
Mammography reports
381.981
Health awareness campaigns
381.982
Short title
381.983
Definitions
381.984
Educational programs
381.985
Screening program
381.986
Medical use of marijuana
381.987
Public records exemption for personal identifying information relating to medical marijuana held by the department
381.988
Medical marijuana testing laboratories
381.989
Public education campaigns
381.991
Andrew John Anderson Pediatric Rare Disease Grant Program
381.02035
Canadian Prescription Drug Importation Program
381.4015
Florida health care innovation
381.4018
Physician workforce assessment and development
381.4019
Dental Student Loan Repayment Program
381.4021
Student loan repayment programs reporting
381.04065
Rural health network cooperative agreements
381.06014
Blood establishments
381.06015
Public Cord Blood Tissue Bank
381.06016
Umbilical cord blood awareness
381.7351
Short title
381.7352
Legislative intent
381.7353
Reducing Racial and Ethnic Health Disparities: Closing the Gap grant program
381.7354
Eligibility
381.7355
Project requirements
381.7356
Local matching funds
381.7395
Legislative intent
381.8531
Florida Center for Brain Tumor Research
381.9312
Uterine fibroid research database
381.9315
Gynecologic and ovarian cancer education and awareness
381.9855
Dr. and Mrs. Alfonse and Kathleen Cinotti Health Care Screening and Services Grant Program
381.40195
Donated Dental Services Program
381.92201
Exemptions from public records and public meetings requirements

Current through Fall 2025

§ 381.0038. Educ.; sterile needle & syringe exchange programs's source at flsenate​.gov